tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Myoclonic Cerebellar Dyssynergia D002527 1 associated lipids
Lichen Nitidus D017513 1 associated lipids
Lichenoid Eruptions D017512 1 associated lipids
Lymphocele D008210 1 associated lipids
Colitis, Collagenous D046729 1 associated lipids
Malacoplakia D008287 1 associated lipids
Hand Injuries D006230 1 associated lipids
Beckwith-Wiedemann Syndrome D001506 1 associated lipids
Eye Diseases, Hereditary D015785 1 associated lipids
Feline Infectious Peritonitis D016766 1 associated lipids
Meningitis, Cryptococcal D016919 1 associated lipids
Oculomotor Nerve Diseases D015840 1 associated lipids
Cutis Laxa D003483 1 associated lipids
Invasive Pulmonary Aspergillosis D055744 1 associated lipids
Intestinal Volvulus D045822 1 associated lipids
IgG Deficiency D017099 1 associated lipids
Deltaretrovirus Infections D006800 1 associated lipids
Hepatopulmonary Syndrome D020065 1 associated lipids
Herpes Labialis D006560 1 associated lipids
End Stage Liver Disease D058625 1 associated lipids
Nocturnal Myoclonus Syndrome D020189 1 associated lipids
Uveomeningoencephalitic Syndrome D014607 1 associated lipids
Myelitis D009187 1 associated lipids
Pseudohypoaldosteronism D011546 1 associated lipids
Dendritic Cell Sarcoma, Interdigitating D054739 1 associated lipids
Polymyositis D017285 1 associated lipids
Scorpion Stings D065008 1 associated lipids
Rotavirus Infections D012400 1 associated lipids
Netherton Syndrome D056770 1 associated lipids
Lymphocytic Choriomeningitis D008216 1 associated lipids
Erythroplasia D004919 1 associated lipids
Hepatic Veno-Occlusive Disease D006504 1 associated lipids
West Nile Fever D014901 1 associated lipids
Hypoalbuminemia D034141 1 associated lipids
Arm Injuries D001134 1 associated lipids
Intussusception D007443 1 associated lipids
Thrombotic Microangiopathies D057049 1 associated lipids
Autoimmune Diseases of the Nervous System D020274 1 associated lipids
Lupus Erythematosus, Discoid D008179 1 associated lipids
Feline Acquired Immunodeficiency Syndrome D016181 1 associated lipids
Budd-Chiari Syndrome D006502 1 associated lipids
AIDS-Associated Nephropathy D016263 1 associated lipids
Oral Ulcer D019226 1 associated lipids
Epidermolysis Bullosa Dystrophica D016108 1 associated lipids
Primary Graft Dysfunction D055031 1 associated lipids
Esophageal Perforation D004939 1 associated lipids
Epididymitis D004823 1 associated lipids
Pruritus Vulvae D011539 1 associated lipids
Central Serous Chorioretinopathy D056833 1 associated lipids
Migraine with Aura D020325 1 associated lipids
Porokeratosis D017499 1 associated lipids
Lentigo D007911 1 associated lipids
Mutism D009155 1 associated lipids
Amyloid Neuropathies D017772 1 associated lipids
Cervical Intraepithelial Neoplasia D018290 1 associated lipids
Flaviviridae Infections D018178 1 associated lipids
Idiopathic Interstitial Pneumonias D054988 1 associated lipids
Dysuria D053159 1 associated lipids
Denys-Drash Syndrome D030321 1 associated lipids
Akinetic Mutism D000405 1 associated lipids
Sleep Apnea, Central D020182 1 associated lipids
Orchitis D009920 1 associated lipids
Phyllodes Tumor D003557 1 associated lipids
Meningitis, Fungal D016921 1 associated lipids
Malocclusion, Angle Class II D008312 1 associated lipids
Vulvar Lichen Sclerosus D007724 1 associated lipids
Cardiomyopathy, Restrictive D002313 1 associated lipids
Paraparesis, Tropical Spastic D015493 1 associated lipids
Neurodermatitis D009450 1 associated lipids
Posterior Leukoencephalopathy Syndrome D054038 1 associated lipids
Ecthyma, Contagious D004474 1 associated lipids
Priapism D011317 1 associated lipids
Panniculitis, Lupus Erythematosus D015435 1 associated lipids
Retrognathia D063173 1 associated lipids
Mediastinal Diseases D008477 1 associated lipids
Hypophosphatemia D017674 1 associated lipids
Leukemia, Myeloid, Chronic-Phase D015466 1 associated lipids
Myelinolysis, Central Pontine D017590 1 associated lipids
Protoporphyria, Erythropoietic D046351 1 associated lipids
Smooth Muscle Tumor D018235 1 associated lipids
Coproporphyria, Hereditary D046349 1 associated lipids
Ichthyosiform Erythroderma, Congenital D016113 1 associated lipids
Kaposi Varicelliform Eruption D007617 1 associated lipids
Lacerations D022125 1 associated lipids
Megacolon, Toxic D008532 1 associated lipids
Tinea Capitis D014006 1 associated lipids
Digestive System Fistula D016154 1 associated lipids
Crigler-Najjar Syndrome D003414 1 associated lipids
Leukoplakia, Oral D007972 1 associated lipids
Peroneal Neuropathies D020427 1 associated lipids
Poxviridae Infections D011213 1 associated lipids
Lymphohistiocytosis, Hemophagocytic D051359 1 associated lipids
Rheumatoid Nodule D012218 1 associated lipids
Hernia, Ventral D006555 1 associated lipids
Hepatitis, Autoimmune D019693 1 associated lipids
Moyamoya Disease D009072 1 associated lipids
Polyomavirus Infections D027601 1 associated lipids
Echinostomiasis D004451 1 associated lipids
Multiple Endocrine Neoplasia Type 2a D018813 1 associated lipids
Apraxias D001072 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Haagsma EB et al. Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens. 2003 Aliment. Pharmacol. Ther. pmid:12848624
Weinberg JM et al. Atopic dermatitis: a new treatment paradigm using pimecrolimus. 2003 J Drugs Dermatol pmid:12852364
Kalia N et al. Mucosal villus microcirculatory disturbances associated with rat intestinal ischaemia-reperfusion injury are not prevented by tacrolimus. 2003 Digestion pmid:12853727
Tocci MJ and Sigal NH Recent advances in the mechanism of action of cyclosporine and FK506. 1992 Curr. Opin. Nephrol. Hypertens. pmid:1285380
Bavandi A et al. Diet-induced dermatitis response of hairless rats to systemic treatment with cyclosporin A (Sandimmun), cyclosporin H and FK506. 1992 Exp. Dermatol. pmid:1285411
High KP and Handschumacher RE Immunity, microbial pathogenesis, and immunophilins: finding the keys, now where are the locks? 1992 Infect Agents Dis pmid:1285413
Mijal J et al. Formation of synapses between dendritic cells and lymphocytes in skin lymph in an allogeneic reaction. 2002 Ann. Transplant. pmid:12854345
Kyles AE et al. Pharmacokinetics of tacrolimus after multidose oral administration and efficacy in the prevention of allograft rejection in cats with renal transplants. 2003 Am. J. Vet. Res. pmid:12856780
Cosio FG and Larson TS Cardiovascular disease after transplantation: do we know all of the variables? 2003 Am. J. Transplant. pmid:12859523
Krämer BK et al. Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation. 2003 Am. J. Transplant. pmid:12859533
Ciancio G et al. The use of daclizumab, tacrolimus and mycophenolate mofetil in african-american and Hispanic first renal transplant recipients. 2003 Am. J. Transplant. pmid:12859538
Bunnapradist S et al. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids. 2003 Transplantation pmid:12865780
Pfitzmann R et al. Mycophenolatemofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients. 2003 Transplantation pmid:12865798
Katsura K et al. Effects of FK506 on the translocation of protein kinase C and CaM kinase II in the gerbil hippocampal CA1 neurons. 2003 Neurol. Res. pmid:12866202
Matsuda S and Koyasu S Regulation of MAPK signaling pathways through immunophilin-ligand complex. 2003 Curr Top Med Chem pmid:12871167
Gold BG and Villafranca JE Neuroimmunophilin ligands: the development of novel neuroregenerative/ neuroprotective compounds. 2003 Curr Top Med Chem pmid:12871168
Avramut M and Achim CL Immunophilins in nervous system degeneration and regeneration. 2003 Curr Top Med Chem pmid:12871169
Arya M et al. Glycoprotein Ib-IX-mediated activation of integrin alpha(IIb)beta(3): effects of receptor clustering and von Willebrand factor adhesion. 2003 J. Thromb. Haemost. pmid:12871313
Muramoto M et al. Detailed in vitro pharmacological analysis of FK506-induced neuroprotection. 2003 Neuropharmacology pmid:12871656
Lan CC et al. Tacrolimus ointment for the treatment of atopic dermatitis: report of first clinical experience in Taiwan. 2003 Kaohsiung J. Med. Sci. pmid:12873038
Cantin B et al. Post-operative conversion from cyclosporine to tacrolimus in heart transplantation: a single-center experience. 2003 J. Heart Lung Transplant. pmid:12873539
Kunstfeld R et al. Successful treatment of vulvar lichen sclerosus with topical tacrolimus. 2003 Arch Dermatol pmid:12873877
Böhm M et al. Successful treatment of anogenital lichen sclerosus with topical tacrolimus. 2003 Arch Dermatol pmid:12873890
Mignen O et al. Calcineurin directs the reciprocal regulation of calcium entry pathways in nonexcitable cells. 2003 J. Biol. Chem. pmid:12874277
Kiemeneij IM et al. Acute headache as a presenting symptom of tacrolimus encephalopathy. 2003 J. Neurol. Neurosurg. Psychiatr. pmid:12876250
Balogh A et al. Can xipamide or tacrolimus inhibit the glucuronidation of mycophenolic acid in rat liver slices? 2003 Exp. Toxicol. Pathol. pmid:12877348
Lupp A et al. Cyclosporine A and tacrolimus: in vitro investigations on the differential interactions with the cytochrome P450 system in rat and human liver. 2003 Exp. Toxicol. Pathol. pmid:12877359
Ciecierski R and Paczek L [Regulatory mechanisms and the influence of immunosuppressive drugs on liver regeneration after partial hepatectomy]. 2003 Pol. Arch. Med. Wewn. pmid:12879782
Nakazato T et al. Reversible posterior leukoencephalopathy syndrome associated with tacrolimus therapy. 2003 Intern. Med. pmid:12879959
Butani L et al. Amelioration of tacrolimus-induced nephrotoxicity in rats using juniper oil. 2003 Transplantation pmid:12883183
Schmidt LE et al. Relationship between postoperative erythromycin breath test and early morbidity in liver transplant recipients. 2003 Transplantation pmid:12883193
Troppmann C et al. Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study. 2003 Transplantation pmid:12883205
Therapondos G et al. Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both? 2003 Transplantation pmid:12883220
Ogunseinde BA et al. A case of tacrolimus (FK506)-induced pancreatitis and fatality 2 years postcadaveric renal transplant. 2003 Transplantation pmid:12883222
Kuypers DR et al. Long-term pharmacokinetic study of the novel combination of tacrolimus and sirolimus in de novo renal allograft recipients. 2003 Ther Drug Monit pmid:12883227
Cervelli MJ and Russ GR Itraconazole-tacrolimus drug interaction. 2003 Ther Drug Monit pmid:12883234
Rao NG and Pariser RJ Annular erythema responding to tacrolimus ointment. 2003 J Drugs Dermatol pmid:12884468
Tanabe K Calcineurin inhibitors in renal transplantation: what is the best option? 2003 Drugs pmid:12887261
Santos JB and Schauwecker PE Protection provided by cyclosporin A against excitotoxic neuronal death is genotype dependent. 2003 Epilepsia pmid:12887430
Ciardella AP et al. Cytomegalovirus retinitis and FK 506. 2003 Am. J. Ophthalmol. pmid:12888078
Al-Uzri A et al. Anemia in children after transplantation: etiology and the effect of immunosuppressive therapy on erythropoiesis. 2003 Pediatr Transplant pmid:12890002
Bens G et al. Topical treatment of Netherton's syndrome with tacrolimus ointment without significant systemic absorption. 2003 Br. J. Dermatol. pmid:12890237
Sandborn WJ et al. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. 2003 Gastroenterology pmid:12891539
Crenesse D et al. Rat liver ischemia-reperfusion-induced apoptosis and necrosis are decreased by FK506 pretreatment. 2003 Eur. J. Pharmacol. pmid:12892836
Coelho FF et al. Use of tacrolimus in rescue therapy of acute and chronic rejection in liver transplantation. 2003 May-Jun Rev Hosp Clin Fac Med Sao Paulo pmid:12894310
Renders L et al. Tacrolimus and cerivastatin pharmacokinetics and adverse effects after single and multiple dosing with cerivastatin in renal transplant recipients. 2003 Br J Clin Pharmacol pmid:12895195
Yang FC et al. [Influence of combined cyclosporine A and tacrolimus with 5-fluorouracil on hepatocellular carcinoma rats]. 2003 Zhonghua Wai Ke Za Zhi pmid:12895356
Stammberger U et al. Strong additive effect of 1,25-dihydroxycholecalciferol and cyclosporine A but not tacrolimus in rat lung allotransplantation. 2003 Eur J Cardiothorac Surg pmid:12895607
Vallet-Pichard A et al. Veno-occlusive disease of the liver in renal transplant patients. 2003 Nephrol. Dial. Transplant. pmid:12897112
Nelson M et al. Tacrolimus and mycophenolate mofetil provide effective immunosuppression in rat laryngeal transplantation. 2003 Laryngoscope pmid:12897551
Verma PS and Gallagher CM Dyspnea on exertion, fatigue, and pallor in a 50-year-old active duty soldier. 2003 Mil Med pmid:12901473
Vennarecci G et al. [Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)]. 2003 Jul-Aug Tumori pmid:12903579
Udina E et al. Comparative dose-dependence study of FK506 on transected mouse sciatic nerve repaired by allograft or xenograft. 2003 J. Peripher. Nerv. Syst. pmid:12904235
Perez-Abadia G et al. Low-dose immunosuppression in a rat hind-limb transplantation model. 2003 Transpl. Int. pmid:12904844
Brook NR et al. Fibrosis-associated gene expression in renal transplant glomeruli after acute renal allograft rejection. 2003 Br J Surg pmid:12905557
Tuñón MJ et al. Effects of FK506 and rapamycin on generation of reactive oxygen species, nitric oxide production and nuclear factor kappa B activation in rat hepatocytes. 2003 Biochem. Pharmacol. pmid:12907243
Meykadeh N and Hengge UR [Topical immunomodulators in dermatology]. 2003 Hautarzt pmid:12908453
Verleden GM et al. Effect of switching from cyclosporine to tacrolimus on exhaled nitric oxide and pulmonary function in patients with chronic rejection after lung transplantation. 2003 J. Heart Lung Transplant. pmid:12909472
Pandher BS et al. Treatment of balanitis xerotica obliterans with topical tacrolimus. 2003 J. Urol. pmid:12913735
Koprak S et al. Down-regulation of cell surface CXCR6 expression during T cell activation is predominantly mediated by calcineurin. 2003 Cell. Immunol. pmid:12914753
Artik S and Ruzicka T Complementary therapy for atopic eczema and other allergic skin diseases. 2003 Dermatol Ther pmid:12919117
Hesselink DA et al. Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids. 2003 Br J Clin Pharmacol pmid:12919182
Lübbe J et al. Rosaceiform dermatitis with follicular Demodex after treatment of facial atopic dermatitis with 1% pimecrolimus cream. 2003 Dermatology (Basel) pmid:12920379
Cherikh WS et al. A comparison of discharge immunosuppressive drug regimens in primary cadaveric kidney transplantation. 2003 Transplantation pmid:12923430
Zieliński A et al. Simultaneous pancreas-kidney transplant from living related donor: a single-center experience. 2003 Transplantation pmid:12923442
Erickson LM et al. Microarray-based gene expression profiles of allograft rejection and immunosuppression in the rat heart transplantation model. 2003 Transplantation pmid:12923448
Maluccio M et al. Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression. 2003 Transplantation pmid:12923450
Pascher A et al. Successful infliximab treatment of steroid and OKT3 refractory acute cellular rejection in two patients after intestinal transplantation. 2003 Transplantation pmid:12923454
Tischmeyer W et al. Rapamycin-sensitive signalling in long-term consolidation of auditory cortex-dependent memory. 2003 Eur. J. Neurosci. pmid:12925020
Hall VC et al. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment. 2003 Arch Dermatol pmid:12925404
Luchowska E et al. FK506 attenuates 1-methyl-4-phenylpyridinium- and 3-nitropropionic acid-evoked inhibition of kynurenic acid synthesis in rat cortical slices. 2003 Acta Neurobiol Exp (Wars) pmid:12926536
Masuda K et al. Increased levels of serum interleukin-16 in adult type atopic dermatitis. 2003 Acta Derm. Venereol. pmid:12926794
Yamamoto T and Nishioka K Deep dermatophytosis during topical tacrolimus therapy for psoriasis. 2003 Acta Derm. Venereol. pmid:12926803
Sand C Topical tacrolimus ointment may induce skin tags in treated patients. 2003 Acta Derm. Venereol. pmid:12926817
Brecht S et al. Changes in peptidyl-prolyl cis/trans isomerase activity and FK506 binding protein expression following neuroprotection by FK506 in the ischemic rat brain. 2003 Neuroscience pmid:12927209
Kalthoff FS et al. Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corticosteroids. 2003 Clin. Exp. Immunol. pmid:12930360
Clayton TH et al. Topical tacrolimus for facial psoriasis. 2003 Br. J. Dermatol. pmid:12932257
Madhavan R et al. The involvement of calcineurin in acetylcholine receptor redistribution in muscle. 2003 Mol. Cell. Neurosci. pmid:12932439
Kinoshita T et al. Diffusion-weighted MR imaging of posterior reversible leukoencephalopathy syndrome: a pictorial essay. 2003 Sep-Oct Clin Imaging pmid:12932680
Gebert B et al. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. 2003 Science pmid:12934009
Gomez-Cambronero J Rapamycin inhibits GM-CSF-induced neutrophil migration. 2003 FEBS Lett. pmid:12935893
Mootz HD et al. Conditional protein splicing: a new tool to control protein structure and function in vitro and in vivo. 2003 J. Am. Chem. Soc. pmid:12940738
Högenauer C et al. Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis. 2003 Aliment. Pharmacol. Ther. pmid:12940927
Gupta AK and Chow M Pimecrolimus: a review. 2003 J Eur Acad Dermatol Venereol pmid:12941081
Yoshida Y et al. FK506-associated limbic injury following umbilical cord blood transplantation. 2003 Bone Marrow Transplant. pmid:12942100
Hamawy MM Molecular actions of calcineurin inhibitors. 2003 Drug News Perspect. pmid:12942158
Jain AB et al. Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients. 2003 Liver Transpl. pmid:12942457
Frühauf NR et al. Late onset of tacrolimus-related posterior leukoencephalopathy after living donor liver transplantation. 2003 Liver Transpl. pmid:12942462
Shainhouse T and Eichenfield LF Long-term safety of tacrolimus ointment in children treated for atopic dermatitis. 2003 Expert Opin Drug Saf pmid:12946246
Croxtall JD et al. Differential modulation of glucocorticoid action by FK506 in A549 cells. 2003 Biochem. J. pmid:12948397
Ruzicka T et al. Potential future dermatological indications for tacrolimus ointment. 2003 Jul-Aug Eur J Dermatol pmid:12948911
Yang W et al. Regulation of gene expression by synthetic dimerizers with novel specificity. 2003 Bioorg. Med. Chem. Lett. pmid:12951089
Brownell I et al. Topical pimecrolimus in the treatment of seborrheic dermatitis. 2003 Dermatol. Online J. pmid:12952760
Alphey MS et al. The crystal structure of Leishmania major 3-mercaptopyruvate sulfurtransferase. A three-domain architecture with a serine protease-like triad at the active site. 2003 J. Biol. Chem. pmid:12952945
Meyrier A Treatment of idiopathic nephrosis by immunophillin modulation. 2003 Nephrol. Dial. Transplant. pmid:12953048
Tada H et al. Chronopharmacokinetics of tacrolimus in kidney transplant recipients: occurrence of acute rejection. 2003 J Clin Pharmacol pmid:12953343
Kuypers DR et al. Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients. 2003 J Clin Pharmacol pmid:12953344
Pabby A et al. Combination therapy of tetracycline and tacrolimus resulting in rapid resolution of steroid-induced periocular rosacea. 2003 Cutis pmid:12953939
Torok HM et al. Clocortolone pivalate cream 0.1% used concomitantly with tacrolimus ointment 0.1% in atopic dermatitis. 2003 Cutis pmid:12953943
Patel N et al. The use of oral tacrolimus in a case of short bowel syndrome. 2004 Transpl. Int. pmid:12955349